Trending stocks

Changmao Biochemical Engineering Co Ltd reports 52.9% CAPEX decline and 8.3% Revenue decline

16/03/2016 • About Changmao Biochemical Engineering Co Ltd ($954) • By InTwits

Changmao Biochemical Engineering Co Ltd reported 2015 financial results today. Overall the company's long term financial model is characterised by the following facts:
  • Changmao Biochemical Engineering Co Ltd has medium CAPEX intensity: 5 year average CAPEX/Revenue was 8.1%. At the same time it's a lot of higher than industry average of 13.1%.
  • CAPEX is quite volatile: 18.6 in 2015, 25.2 in 2014, 10.3 in 2013, 14.1 in 2012, 62.9 in 2011
  • The company has potentially unprofitable business model: ROIC is at 6.3%
Below you can find a comprehensive analysis of the key data driving the company's performance and stock price.

Changmao Biochemical Engineering Co Ltd ($954) key annual financial indicators

mln. CNY201120122013201420152015/2014
P&L
Revenue620.2653.2703.0561.7514.8-8.3%
Gross Profit114.2127.5169.0111.3114.83.1%
SG&A77.684.573.274.72.1%
EBITDA94.4103.0121.378.979.00.2%
Net Income41.149.570.037.245.321.6%
Balance Sheet
Cash59.6108.264.861.795.855.2%
Short Term Debt181.9144.5105.0113.2119.45.5%
Long Term Debt0.00.00.00.00.0
Cash flow
Capex51.742.158.464.930.6-52.9%
Ratios
Revenue growth20.3%5.3%7.6%-20.1%-8.3%
EBITDA growth-17.6%9.2%17.8%-35.0%0.2%
Gross Margin18.4%19.5%24.0%19.8%22.3%2.5%
EBITDA Margin15.2%15.8%17.3%14.0%15.4%1.3%
Net Income Margin6.6%7.6%10.0%6.6%8.8%2.2%
SG&A, % of revenue11.9%12.0%13.0%14.5%1.5%
CAPEX, % of revenue8.3%6.4%8.3%11.6%5.9%-5.6%
ROIC10.9%10.8%13.9%7.1%6.3%-0.8%
ROE9.9%11.1%14.3%7.1%8.2%1.1%
Net Debt/EBITDA1.3x0.4x0.3x0.7x0.3x-0.4x

Revenue and profitability


The company's Revenue decreased on 8.3% in 2015. Having declining revenue the company managed to increase EBITDA margin. EBITDA Margin increased slightly on 1.3 pp from 14.0% to 15.4% in 2015.

Gross Margin increased on 2.5 pp from 19.8% to 22.3% in 2015. SG&A as a % of Revenue increased slightly on 1.5 pp from 13.0% to 14.5% in 2015.

Net Income marign increased on 2.2 pp from 6.6% to 8.8% in 2015.

Capital expenditures (CAPEX) and working capital investments


In 2015 Changmao Biochemical Engineering Co Ltd had CAPEX/Revenue of 5.9%. CAPEX/Revenue decreased slightly on 0.51 pp from 6.4% in 2012 to 5.9% in 2015. It's average level of CAPEX/Revenue for the last three years was 8.6%.

Return on investment


The company operates at low ROIC (6.32%) and ROE (8.23%). ROIC decreased slightly on 0.75 pp from 7.1% to 6.3% in 2015. ROE increased slightly on 1.1 pp from 7.1% to 8.2% in 2015.

Leverage (Debt)


Debt level is 0.3x Net Debt / EBITDA and 1.5x Debt / EBITDA. Net Debt / EBITDA dropped on 0.4x from 0.7x to 0.3x in 2015. Debt increased on 5.5% in 2015 while cash surged on 55.2% in 2015.

Appendix 1: Peers in Chemicals


Below you can find Changmao Biochemical Engineering Co Ltd benchmarking vs. other companies in Chemicals industry. It's shown for the period of 5 years for the key financial metrics. Each table has median value for all the companies in the industry together with individual financial data of the top-5 companies in the industry by particular financial metric.

Top companies by Revenue growth, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Bestway International Holdings Ltd ($718)-25.4%-62.1%330.3%238.4%
Jilin Qifeng Chemical Fiber Co Ltd ($549)39.7%-33.6%5.5%29.1%
China XLX Fertiliser Ltd ($1866)7.0%0.6%28.0%13.9%
Century Sunshine Group Holdings Ltd ($509)49.2%68.7%32.0%26.4%
Landing International Development Ltd ($582)-50.7%2.1%15.9%23.3%
 
Median (31 companies)34.7%2.0%10.1%2.2%-0.6%
Changmao Biochemical Engineering Co Ltd ($954)5.3%7.6%-20.1%-8.3%


Top companies by Gross margin, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Huabao International Holdings Ltd ($336)74.3%70.5%69.1%70.8%69.9%
China Flavors & Fragrances Co Ltd ($3318)41.3%46.8%48.6%47.8%48.9%
Smartac Group China Holdings Ltd ($395)17.3%-1.8%11.2%40.4%
Bracell Ltd ($1768)40.1%30.5%37.3%37.3%38.4%
Yingde Gases Group Co Ltd ($2168)34.2%31.7%31.0%32.1%
 
Median (31 companies)19.8%18.2%16.2%16.0%28.2%
Changmao Biochemical Engineering Co Ltd ($954)18.4%19.5%24.0%19.8%22.3%


Top companies by EBITDA margin, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Huabao International Holdings Ltd ($336)66.4%63.8%59.1%60.0%58.3%
Bracell Ltd ($1768)30.1%22.3%30.8%38.2%35.9%
Yingde Gases Group Co Ltd ($2168)32.3%29.4%29.8%32.3%
China First Chemical Holdings Ltd ($2121)29.7%26.6%30.0%29.6%
Century Sunshine Group Holdings Ltd ($509)15.5%24.2%28.1%27.6%
 
Median (31 companies)15.5%13.2%12.7%11.1%14.2%
Changmao Biochemical Engineering Co Ltd ($954)15.2%15.8%17.3%14.0%15.4%


Top companies by CAPEX/Revenue, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Landing International Development Ltd ($582)27.9%7.2%29.6%419.5%
China Zenith Chemical Group Ltd ($362)36.8%147.3%55.7%67.4%152.2%
Smartac Group China Holdings Ltd ($395)22.5%14.0%4.7%49.3%
China Flavors & Fragrances Co Ltd ($3318)16.4%15.8%20.1%42.4%35.8%
Bracell Ltd ($1768)24.4%22.3%64.3%35.4%11.7%
 
Median (31 companies)8.7%9.6%8.7%5.1%8.1%
Changmao Biochemical Engineering Co Ltd ($954)8.3%6.4%8.3%11.6%5.9%


Top companies by ROIC, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Huabao International Holdings Ltd ($336)34.6%28.7%25.2%26.2%23.3%
Tiande Chemical Holdings Ltd ($609)24.4%26.2%29.4%20.7%20.6%
Century Sunshine Group Holdings Ltd ($509)3.5%11.3%15.9%16.4%
Fufeng Group Ltd ($546)13.9%9.6%10.8%11.6%10.3%
Yingde Gases Group Co Ltd ($2168)14.7%10.6%11.5%11.5%
 
Median (31 companies)7.8%6.9%7.4%5.2%8.2%
Changmao Biochemical Engineering Co Ltd ($954)10.9%10.8%13.9%7.1%6.3%


Top companies by Net Debt / EBITDA

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
China Sanjiang Fine Chemicals Co Ltd ($2198)2.4x2.2x4.6x18.1x
China XLX Fertiliser Ltd ($1866)2.4x2.6x5.1x5.8x5.1x
Ngai Hing Hong Co Ltd ($1047)4.8x11.7x5.3x5.4x5.3x
Jilin Qifeng Chemical Fiber Co Ltd ($549)4.3x14.1x6.5x5.3x
Sinofert Holdings Ltd ($297)4.3x2.9x32.4x5.0x
 
Median (24 companies)1.5x1.9x2.5x1.5x0.2x
Changmao Biochemical Engineering Co Ltd ($954)1.3x0.4x0.3x0.7x0.3x